Sun Pharmaceutical Industries Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is LEVALBUTEROL HYDROCHLORIDE USP, with a corresponding US DMF Number 27663.
Remarkably, this DMF maintains an Active status since its submission on February 14, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 27, 2014, and payment made on February 14, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II